safusidenib Clinical Trials

1 actively recruiting trial across 1 location

Also known as: AB-218, DS-1001b

Filter by location:

Birmingham, Alabama1 trial

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

University of Alabama

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.